Literature DB >> 19223518

Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.

Teresa Sir-Petermann1, Ethel Codner, Virginia Pérez, Bárbara Echiburú, Manuel Maliqueo, Amanda Ladrón de Guevara, Jessica Preisler, Nicolás Crisosto, Fernando Sánchez, Fernando Cassorla, Shalender Bhasin.   

Abstract

CONTEXT: A significant proportion of the first-degree female relatives of women with polycystic ovary syndrome (PCOS) may be at risk for developing PCOS. However, it is not known at which stage of pubertal development the hormonal and metabolic abnormalities ensue in PCOS.
OBJECTIVE: The aim of the study was to assess the reproductive and metabolic profiles of daughters of women with PCOS (PCOSd) during the peripubertal period, a stage during which the gonadal axis is activated and PCOS may become clinically manifest.
DESIGN: Ninety-nine PCOSd [30 prepubertal and 69 pubertal (Tanner II-V)] and 84 daughters of control women (Cd) (20 prepubertal and 64 pubertal) were studied. An oral glucose tolerance test, a GnRH agonist test (leuprolide acetate, 10 microg/kg sc), and a transabdominal ultrasound were performed. Gonadotropins, sex steroids, SHBG, glucose, insulin, and lipids were determined.
RESULTS: Both groups had similar chronological ages and body mass index sd scores according to Tanner stage distribution. Ovarian volume and 2-h insulin were significantly higher in PCOSd compared to Cd at all Tanner stages. In Tanner stages IV and V, basal testosterone and poststimulated LH, testosterone, and 17-hydroxyprogesterone concentrations were significantly higher in PCOSd compared to Cd.
CONCLUSIONS: Hyperinsulinemia and an increased ovarian volume are present in PCOSd before the onset of puberty and persist during pubertal development. The biochemical abnormalities of PCOS appear during late puberty. Considering the early onset and the nature of the alterations, PCOSd constitute a high-risk group for metabolic and reproductive derangements.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223518      PMCID: PMC2730345          DOI: 10.1210/jc.2008-2836

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  54 in total

Review 1.  Puberty and polycystic ovary syndrome.

Authors:  Selma Feldman Witchel
Journal:  Mol Cell Endocrinol       Date:  2006-06-05       Impact factor: 4.102

Review 2.  Clinical review: Identifying children at risk for polycystic ovary syndrome.

Authors:  Robert L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  2006-12-19       Impact factor: 5.958

3.  [Fasting glucose versus oral glucose tolerance test for detection of glucose intolerance in obese children].

Authors:  Vivian Gallardo T; Alejandra Avila A; Nancy Unuane M; Ethel Codner
Journal:  Rev Med Chil       Date:  2006-12-12       Impact factor: 0.553

4.  Functional significance of polycystic-size ovaries in healthy adolescents.

Authors:  Monica Mortensen; Robert L Rosenfield; Elizabeth Littlejohn
Journal:  J Clin Endocrinol Metab       Date:  2006-08-08       Impact factor: 5.958

5.  Longitudinal study of physiologic insulin resistance and metabolic changes of puberty.

Authors:  Tamara S Hannon; Janine Janosky; Silva A Arslanian
Journal:  Pediatr Res       Date:  2006-10-25       Impact factor: 3.756

6.  Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome.

Authors:  Manuel Luque-Ramírez; Francisco Alvarez-Blasco; Covadonga Mendieta-Azcona; José I Botella-Carretero; Héctor F Escobar-Morreale
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

7.  Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.

Authors:  William Rosner; Richard J Auchus; Ricardo Azziz; Patrick M Sluss; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

8.  Gonadal function in low birth weight infants: a pilot study.

Authors:  Teresa Sir-Petermann; Catalina Hitchsfeld; Ethel Codner; Manuel Maliqueo; Germán Iñiguez; Bárbara Echiburú; Fernando Sánchez; Nicolas Crisosto; Fernando Cassorla
Journal:  J Pediatr Endocrinol Metab       Date:  2007-03       Impact factor: 1.634

9.  Impact of obesity on the risk for polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Eric S Knochenhauer; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

10.  Early metabolic derangements in daughters of women with polycystic ovary syndrome.

Authors:  Teresa Sir-Petermann; Manuel Maliqueo; Ethel Codner; Bárbara Echiburú; Nicolás Crisosto; Virginia Pérez; Francisco Pérez-Bravo; Fernando Cassorla
Journal:  J Clin Endocrinol Metab       Date:  2007-09-11       Impact factor: 5.958

View more
  96 in total

Review 1.  PCOS in adolescence and type 2 diabetes.

Authors:  Anne-Marie Carreau; Jean-Patrice Baillargeon
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

Review 2.  Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

Authors:  Selma F Witchel; Sergio E Recabarren; Frank González; Evanthia Diamanti-Kandarakis; Kai I Cheang; Antoni J Duleba; Richard S Legro; Roy Homburg; Renato Pasquali; Rogerio A Lobo; Christos C Zouboulis; Fahrettin Kelestimur; Franca Fruzzetti; Walter Futterweit; Robert J Norman; David H Abbott
Journal:  Endocrine       Date:  2012-06-04       Impact factor: 3.633

3.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

Review 4.  Developmental Programming, a Pathway to Disease.

Authors:  Vasantha Padmanabhan; Rodolfo C Cardoso; Muraly Puttabyatappa
Journal:  Endocrinology       Date:  2016-02-09       Impact factor: 4.736

5.  Female Offspring From Chronic Hyperandrogenemic Dams Exhibit Delayed Puberty and Impaired Ovarian Reserve.

Authors:  Zhiqiang Wang; Mingjie Shen; Ping Xue; Sara A DiVall; James Segars; Sheng Wu
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

6.  DNA methylation in promoter regions of genes involved in the reproductive and metabolic function of children born to women with PCOS.

Authors:  Bárbara Echiburú; Fermín Milagro; Nicolás Crisosto; Francisco Pérez-Bravo; Cristian Flores; Ana Arpón; Francisca Salas-Pérez; Sergio E Recabarren; Teresa Sir-Petermann; Manuel Maliqueo
Journal:  Epigenetics       Date:  2020-04-20       Impact factor: 4.528

Review 7.  Mechanisms of intergenerational transmission of polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Luis R Hoyos; Gregorio D Chazenbalk; Rajanigandha Naik; Vasantha Padmanabhan; David H Abbott
Journal:  Reproduction       Date:  2020-01       Impact factor: 3.906

Review 8.  Developmental programming of insulin resistance: are androgens the culprits?

Authors:  Muraly Puttabyatappa; Robert M Sargis; Vasantha Padmanabhan
Journal:  J Endocrinol       Date:  2020-06       Impact factor: 4.286

Review 9.  Gestational Hyperandrogenism in Developmental Programming.

Authors:  Christopher Hakim; Vasantha Padmanabhan; Arpita K Vyas
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

10.  Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females.

Authors:  V Padmanabhan; A Veiga-Lopez; D H Abbott; S E Recabarren; C Herkimer
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.